nodes	percent_of_prediction	percent_of_DWPC	metapath
Granisetron—CYP1A1—Dacarbazine—muscle cancer	0.402	0.487	CbGbCtD
Granisetron—CYP3A5—Vincristine—muscle cancer	0.129	0.156	CbGbCtD
Granisetron—CYP3A5—Etoposide—muscle cancer	0.118	0.143	CbGbCtD
Granisetron—CYP3A4—Vincristine—muscle cancer	0.0502	0.0608	CbGbCtD
Granisetron—CYP2D6—Doxorubicin—muscle cancer	0.0494	0.0598	CbGbCtD
Granisetron—CYP3A4—Etoposide—muscle cancer	0.046	0.0557	CbGbCtD
Granisetron—CYP3A4—Doxorubicin—muscle cancer	0.0314	0.038	CbGbCtD
Granisetron—Ill-defined disorder—Dactinomycin—muscle cancer	0.00102	0.00584	CcSEcCtD
Granisetron—Anaemia—Dactinomycin—muscle cancer	0.00102	0.00582	CcSEcCtD
Granisetron—Dyskinesia—Doxorubicin—muscle cancer	0.001	0.00575	CcSEcCtD
Granisetron—Alopecia—Vincristine—muscle cancer	0.000997	0.00571	CcSEcCtD
Granisetron—Coma—Methotrexate—muscle cancer	0.000996	0.00571	CcSEcCtD
Granisetron—Jaundice—Etoposide—muscle cancer	0.000993	0.00568	CcSEcCtD
Granisetron—Malaise—Dactinomycin—muscle cancer	0.000991	0.00568	CcSEcCtD
Granisetron—Leukopenia—Dactinomycin—muscle cancer	0.000984	0.00564	CcSEcCtD
Granisetron—Atrioventricular block—Doxorubicin—muscle cancer	0.000973	0.00557	CcSEcCtD
Granisetron—Hepatobiliary disease—Etoposide—muscle cancer	0.000963	0.00552	CcSEcCtD
Granisetron—Hepatocellular injury—Doxorubicin—muscle cancer	0.000944	0.00541	CcSEcCtD
Granisetron—Hiccups—Doxorubicin—muscle cancer	0.000944	0.00541	CcSEcCtD
Granisetron—Discomfort—Dactinomycin—muscle cancer	0.000925	0.0053	CcSEcCtD
Granisetron—Melaena—Doxorubicin—muscle cancer	0.000922	0.00528	CcSEcCtD
Granisetron—Anaemia—Vincristine—muscle cancer	0.000908	0.0052	CcSEcCtD
Granisetron—Agitation—Vincristine—muscle cancer	0.000903	0.00517	CcSEcCtD
Granisetron—Photosensitivity—Methotrexate—muscle cancer	0.000901	0.00516	CcSEcCtD
Granisetron—Oedema—Dactinomycin—muscle cancer	0.000897	0.00514	CcSEcCtD
Granisetron—Fluid retention—Doxorubicin—muscle cancer	0.000896	0.00513	CcSEcCtD
Granisetron—Infection—Dactinomycin—muscle cancer	0.000891	0.00511	CcSEcCtD
Granisetron—Vertigo—Vincristine—muscle cancer	0.000883	0.00505	CcSEcCtD
Granisetron—Leukopenia—Vincristine—muscle cancer	0.000879	0.00504	CcSEcCtD
Granisetron—Thrombocytopenia—Dactinomycin—muscle cancer	0.000879	0.00503	CcSEcCtD
Granisetron—Coma—Doxorubicin—muscle cancer	0.000863	0.00494	CcSEcCtD
Granisetron—Flushing—Etoposide—muscle cancer	0.000848	0.00486	CcSEcCtD
Granisetron—Hypertension—Vincristine—muscle cancer	0.000848	0.00486	CcSEcCtD
Granisetron—Angiopathy—Etoposide—muscle cancer	0.000829	0.00475	CcSEcCtD
Granisetron—Abnormal vision—Doxorubicin—muscle cancer	0.000823	0.00472	CcSEcCtD
Granisetron—Chills—Etoposide—muscle cancer	0.00082	0.0047	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000818	0.00468	CcSEcCtD
Granisetron—Alopecia—Etoposide—muscle cancer	0.000808	0.00463	CcSEcCtD
Granisetron—Oedema—Vincristine—muscle cancer	0.000802	0.00459	CcSEcCtD
Granisetron—Anaphylactic shock—Vincristine—muscle cancer	0.000802	0.00459	CcSEcCtD
Granisetron—Infection—Vincristine—muscle cancer	0.000796	0.00456	CcSEcCtD
Granisetron—Nervous system disorder—Vincristine—muscle cancer	0.000786	0.0045	CcSEcCtD
Granisetron—Thrombocytopenia—Vincristine—muscle cancer	0.000785	0.0045	CcSEcCtD
Granisetron—Photosensitivity—Doxorubicin—muscle cancer	0.000781	0.00447	CcSEcCtD
Granisetron—Decreased appetite—Dactinomycin—muscle cancer	0.00078	0.00447	CcSEcCtD
Granisetron—Dysgeusia—Etoposide—muscle cancer	0.000779	0.00446	CcSEcCtD
Granisetron—Hyperhidrosis—Vincristine—muscle cancer	0.000775	0.00444	CcSEcCtD
Granisetron—Pain—Dactinomycin—muscle cancer	0.000767	0.00439	CcSEcCtD
Granisetron—Hypotension—Vincristine—muscle cancer	0.000749	0.00429	CcSEcCtD
Granisetron—Feeling abnormal—Dactinomycin—muscle cancer	0.000739	0.00423	CcSEcCtD
Granisetron—Ill-defined disorder—Etoposide—muscle cancer	0.000738	0.00423	CcSEcCtD
Granisetron—Anaemia—Etoposide—muscle cancer	0.000735	0.00421	CcSEcCtD
Granisetron—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000734	0.0042	CcSEcCtD
Granisetron—Liver function test abnormal—Methotrexate—muscle cancer	0.000731	0.00418	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00073	0.00418	CcSEcCtD
Granisetron—Insomnia—Vincristine—muscle cancer	0.000725	0.00415	CcSEcCtD
Granisetron—Paraesthesia—Vincristine—muscle cancer	0.00072	0.00412	CcSEcCtD
Granisetron—Malaise—Etoposide—muscle cancer	0.000718	0.00411	CcSEcCtD
Granisetron—Vertigo—Etoposide—muscle cancer	0.000715	0.00409	CcSEcCtD
Granisetron—Leukopenia—Etoposide—muscle cancer	0.000712	0.00408	CcSEcCtD
Granisetron—Abdominal pain—Dactinomycin—muscle cancer	0.000709	0.00406	CcSEcCtD
Granisetron—Body temperature increased—Dactinomycin—muscle cancer	0.000709	0.00406	CcSEcCtD
Granisetron—Loss of consciousness—Etoposide—muscle cancer	0.000699	0.00401	CcSEcCtD
Granisetron—Decreased appetite—Vincristine—muscle cancer	0.000697	0.00399	CcSEcCtD
Granisetron—Cough—Etoposide—muscle cancer	0.000694	0.00398	CcSEcCtD
Granisetron—Gastrointestinal disorder—Vincristine—muscle cancer	0.000692	0.00396	CcSEcCtD
Granisetron—Hyponatraemia—Doxorubicin—muscle cancer	0.000688	0.00394	CcSEcCtD
Granisetron—Hypertension—Etoposide—muscle cancer	0.000687	0.00393	CcSEcCtD
Granisetron—Pain—Vincristine—muscle cancer	0.000686	0.00393	CcSEcCtD
Granisetron—Constipation—Vincristine—muscle cancer	0.000686	0.00393	CcSEcCtD
Granisetron—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.000685	0.00392	CcSEcCtD
Granisetron—Chest pain—Etoposide—muscle cancer	0.000677	0.00388	CcSEcCtD
Granisetron—Eosinophilia—Methotrexate—muscle cancer	0.000677	0.00388	CcSEcCtD
Granisetron—Migraine—Doxorubicin—muscle cancer	0.000675	0.00386	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000673	0.00385	CcSEcCtD
Granisetron—Discomfort—Etoposide—muscle cancer	0.000669	0.00383	CcSEcCtD
Granisetron—Hypersensitivity—Dactinomycin—muscle cancer	0.000661	0.00379	CcSEcCtD
Granisetron—Gastrointestinal pain—Vincristine—muscle cancer	0.000656	0.00375	CcSEcCtD
Granisetron—Anaphylactic shock—Etoposide—muscle cancer	0.000649	0.00372	CcSEcCtD
Granisetron—Infection—Etoposide—muscle cancer	0.000645	0.00369	CcSEcCtD
Granisetron—Asthenia—Dactinomycin—muscle cancer	0.000644	0.00369	CcSEcCtD
Granisetron—Dysuria—Methotrexate—muscle cancer	0.00064	0.00366	CcSEcCtD
Granisetron—Thrombocytopenia—Etoposide—muscle cancer	0.000636	0.00364	CcSEcCtD
Granisetron—Tachycardia—Etoposide—muscle cancer	0.000634	0.00363	CcSEcCtD
Granisetron—Abdominal pain—Vincristine—muscle cancer	0.000634	0.00363	CcSEcCtD
Granisetron—Body temperature increased—Vincristine—muscle cancer	0.000634	0.00363	CcSEcCtD
Granisetron—Liver function test abnormal—Doxorubicin—muscle cancer	0.000633	0.00362	CcSEcCtD
Granisetron—Skin disorder—Etoposide—muscle cancer	0.000631	0.00361	CcSEcCtD
Granisetron—Hyperhidrosis—Etoposide—muscle cancer	0.000628	0.0036	CcSEcCtD
Granisetron—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000626	0.00358	CcSEcCtD
Granisetron—Photosensitivity reaction—Methotrexate—muscle cancer	0.000624	0.00358	CcSEcCtD
Granisetron—Hypokalaemia—Doxorubicin—muscle cancer	0.000624	0.00357	CcSEcCtD
Granisetron—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000617	0.00353	CcSEcCtD
Granisetron—Diarrhoea—Dactinomycin—muscle cancer	0.000614	0.00352	CcSEcCtD
Granisetron—Hypotension—Etoposide—muscle cancer	0.000607	0.00348	CcSEcCtD
Granisetron—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000604	0.00346	CcSEcCtD
Granisetron—Abdominal distension—Doxorubicin—muscle cancer	0.000596	0.00341	CcSEcCtD
Granisetron—Hypersensitivity—Vincristine—muscle cancer	0.000591	0.00338	CcSEcCtD
Granisetron—Eosinophilia—Doxorubicin—muscle cancer	0.000586	0.00336	CcSEcCtD
Granisetron—Sweating—Methotrexate—muscle cancer	0.000585	0.00335	CcSEcCtD
Granisetron—Paraesthesia—Etoposide—muscle cancer	0.000583	0.00334	CcSEcCtD
Granisetron—Dyspnoea—Etoposide—muscle cancer	0.000579	0.00332	CcSEcCtD
Granisetron—Somnolence—Etoposide—muscle cancer	0.000577	0.00331	CcSEcCtD
Granisetron—Angina pectoris—Doxorubicin—muscle cancer	0.000577	0.0033	CcSEcCtD
Granisetron—Hepatobiliary disease—Methotrexate—muscle cancer	0.000577	0.0033	CcSEcCtD
Granisetron—Epistaxis—Methotrexate—muscle cancer	0.000575	0.00329	CcSEcCtD
Granisetron—Asthenia—Vincristine—muscle cancer	0.000575	0.00329	CcSEcCtD
Granisetron—Vomiting—Dactinomycin—muscle cancer	0.000571	0.00327	CcSEcCtD
Granisetron—Rash—Dactinomycin—muscle cancer	0.000566	0.00324	CcSEcCtD
Granisetron—Decreased appetite—Etoposide—muscle cancer	0.000565	0.00323	CcSEcCtD
Granisetron—Gastrointestinal disorder—Etoposide—muscle cancer	0.000561	0.00321	CcSEcCtD
Granisetron—Pain—Etoposide—muscle cancer	0.000555	0.00318	CcSEcCtD
Granisetron—Constipation—Etoposide—muscle cancer	0.000555	0.00318	CcSEcCtD
Granisetron—Dysuria—Doxorubicin—muscle cancer	0.000554	0.00317	CcSEcCtD
Granisetron—Diarrhoea—Vincristine—muscle cancer	0.000549	0.00314	CcSEcCtD
Granisetron—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000541	0.0031	CcSEcCtD
Granisetron—Feeling abnormal—Etoposide—muscle cancer	0.000535	0.00306	CcSEcCtD
Granisetron—Nausea—Dactinomycin—muscle cancer	0.000533	0.00305	CcSEcCtD
Granisetron—Gastrointestinal pain—Etoposide—muscle cancer	0.000531	0.00304	CcSEcCtD
Granisetron—Dizziness—Vincristine—muscle cancer	0.00053	0.00304	CcSEcCtD
Granisetron—Visual impairment—Methotrexate—muscle cancer	0.000528	0.00302	CcSEcCtD
Granisetron—Urticaria—Etoposide—muscle cancer	0.000516	0.00295	CcSEcCtD
Granisetron—Jaundice—Doxorubicin—muscle cancer	0.000515	0.00295	CcSEcCtD
Granisetron—Abdominal pain—Etoposide—muscle cancer	0.000513	0.00294	CcSEcCtD
Granisetron—Body temperature increased—Etoposide—muscle cancer	0.000513	0.00294	CcSEcCtD
Granisetron—Urinary tract infection—Doxorubicin—muscle cancer	0.000513	0.00294	CcSEcCtD
Granisetron—Vomiting—Vincristine—muscle cancer	0.00051	0.00292	CcSEcCtD
Granisetron—Sweating—Doxorubicin—muscle cancer	0.000506	0.0029	CcSEcCtD
Granisetron—Rash—Vincristine—muscle cancer	0.000505	0.00289	CcSEcCtD
Granisetron—Dermatitis—Vincristine—muscle cancer	0.000505	0.00289	CcSEcCtD
Granisetron—Headache—Vincristine—muscle cancer	0.000502	0.00288	CcSEcCtD
Granisetron—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000499	0.00286	CcSEcCtD
Granisetron—Epistaxis—Doxorubicin—muscle cancer	0.000498	0.00285	CcSEcCtD
Granisetron—Angiopathy—Methotrexate—muscle cancer	0.000497	0.00284	CcSEcCtD
Granisetron—Sinusitis—Doxorubicin—muscle cancer	0.000495	0.00284	CcSEcCtD
Granisetron—Chills—Methotrexate—muscle cancer	0.000491	0.00281	CcSEcCtD
Granisetron—Alopecia—Methotrexate—muscle cancer	0.000484	0.00277	CcSEcCtD
Granisetron—Bradycardia—Doxorubicin—muscle cancer	0.000483	0.00276	CcSEcCtD
Granisetron—Hypersensitivity—Etoposide—muscle cancer	0.000478	0.00274	CcSEcCtD
Granisetron—Malnutrition—Methotrexate—muscle cancer	0.000477	0.00273	CcSEcCtD
Granisetron—Nausea—Vincristine—muscle cancer	0.000476	0.00273	CcSEcCtD
Granisetron—Rhinitis—Doxorubicin—muscle cancer	0.000475	0.00272	CcSEcCtD
Granisetron—Dysgeusia—Methotrexate—muscle cancer	0.000467	0.00267	CcSEcCtD
Granisetron—Asthenia—Etoposide—muscle cancer	0.000466	0.00267	CcSEcCtD
Granisetron—Connective tissue disorder—Doxorubicin—muscle cancer	0.000466	0.00267	CcSEcCtD
Granisetron—Pruritus—Etoposide—muscle cancer	0.000459	0.00263	CcSEcCtD
Granisetron—Visual impairment—Doxorubicin—muscle cancer	0.000457	0.00262	CcSEcCtD
Granisetron—Diarrhoea—Etoposide—muscle cancer	0.000444	0.00254	CcSEcCtD
Granisetron—Ill-defined disorder—Methotrexate—muscle cancer	0.000442	0.00253	CcSEcCtD
Granisetron—Anaemia—Methotrexate—muscle cancer	0.000441	0.00252	CcSEcCtD
Granisetron—Flushing—Doxorubicin—muscle cancer	0.00044	0.00252	CcSEcCtD
Granisetron—Angiopathy—Doxorubicin—muscle cancer	0.00043	0.00246	CcSEcCtD
Granisetron—Malaise—Methotrexate—muscle cancer	0.00043	0.00246	CcSEcCtD
Granisetron—Dizziness—Etoposide—muscle cancer	0.000429	0.00246	CcSEcCtD
Granisetron—Vertigo—Methotrexate—muscle cancer	0.000428	0.00245	CcSEcCtD
Granisetron—Leukopenia—Methotrexate—muscle cancer	0.000427	0.00244	CcSEcCtD
Granisetron—Chills—Doxorubicin—muscle cancer	0.000425	0.00244	CcSEcCtD
Granisetron—Arrhythmia—Doxorubicin—muscle cancer	0.000424	0.00243	CcSEcCtD
Granisetron—Alopecia—Doxorubicin—muscle cancer	0.000419	0.0024	CcSEcCtD
Granisetron—Cough—Methotrexate—muscle cancer	0.000416	0.00238	CcSEcCtD
Granisetron—Vomiting—Etoposide—muscle cancer	0.000413	0.00236	CcSEcCtD
Granisetron—Malnutrition—Doxorubicin—muscle cancer	0.000413	0.00236	CcSEcCtD
Granisetron—Rash—Etoposide—muscle cancer	0.000409	0.00235	CcSEcCtD
Granisetron—Dermatitis—Etoposide—muscle cancer	0.000409	0.00234	CcSEcCtD
Granisetron—Headache—Etoposide—muscle cancer	0.000407	0.00233	CcSEcCtD
Granisetron—Flatulence—Doxorubicin—muscle cancer	0.000407	0.00233	CcSEcCtD
Granisetron—Arthralgia—Methotrexate—muscle cancer	0.000406	0.00232	CcSEcCtD
Granisetron—Chest pain—Methotrexate—muscle cancer	0.000406	0.00232	CcSEcCtD
Granisetron—Tension—Doxorubicin—muscle cancer	0.000405	0.00232	CcSEcCtD
Granisetron—Dysgeusia—Doxorubicin—muscle cancer	0.000404	0.00231	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000403	0.00231	CcSEcCtD
Granisetron—Discomfort—Methotrexate—muscle cancer	0.000401	0.0023	CcSEcCtD
Granisetron—Nervousness—Doxorubicin—muscle cancer	0.000401	0.0023	CcSEcCtD
Granisetron—Anaphylactic shock—Methotrexate—muscle cancer	0.000389	0.00223	CcSEcCtD
Granisetron—Infection—Methotrexate—muscle cancer	0.000386	0.00221	CcSEcCtD
Granisetron—Nausea—Etoposide—muscle cancer	0.000386	0.00221	CcSEcCtD
Granisetron—Ill-defined disorder—Doxorubicin—muscle cancer	0.000383	0.00219	CcSEcCtD
Granisetron—Nervous system disorder—Methotrexate—muscle cancer	0.000381	0.00218	CcSEcCtD
Granisetron—Anaemia—Doxorubicin—muscle cancer	0.000381	0.00218	CcSEcCtD
Granisetron—Thrombocytopenia—Methotrexate—muscle cancer	0.000381	0.00218	CcSEcCtD
Granisetron—Agitation—Doxorubicin—muscle cancer	0.000379	0.00217	CcSEcCtD
Granisetron—Skin disorder—Methotrexate—muscle cancer	0.000378	0.00216	CcSEcCtD
Granisetron—Hyperhidrosis—Methotrexate—muscle cancer	0.000376	0.00215	CcSEcCtD
Granisetron—Malaise—Doxorubicin—muscle cancer	0.000372	0.00213	CcSEcCtD
Granisetron—Vertigo—Doxorubicin—muscle cancer	0.000371	0.00212	CcSEcCtD
Granisetron—Syncope—Doxorubicin—muscle cancer	0.00037	0.00212	CcSEcCtD
Granisetron—Leukopenia—Doxorubicin—muscle cancer	0.000369	0.00212	CcSEcCtD
Granisetron—Palpitations—Doxorubicin—muscle cancer	0.000365	0.00209	CcSEcCtD
Granisetron—Hypotension—Methotrexate—muscle cancer	0.000363	0.00208	CcSEcCtD
Granisetron—Loss of consciousness—Doxorubicin—muscle cancer	0.000363	0.00208	CcSEcCtD
Granisetron—Cough—Doxorubicin—muscle cancer	0.00036	0.00206	CcSEcCtD
Granisetron—Hypertension—Doxorubicin—muscle cancer	0.000356	0.00204	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000354	0.00203	CcSEcCtD
Granisetron—Insomnia—Methotrexate—muscle cancer	0.000352	0.00201	CcSEcCtD
Granisetron—Chest pain—Doxorubicin—muscle cancer	0.000351	0.00201	CcSEcCtD
Granisetron—Arthralgia—Doxorubicin—muscle cancer	0.000351	0.00201	CcSEcCtD
Granisetron—Anxiety—Doxorubicin—muscle cancer	0.00035	0.00201	CcSEcCtD
Granisetron—Paraesthesia—Methotrexate—muscle cancer	0.000349	0.002	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000349	0.002	CcSEcCtD
Granisetron—Discomfort—Doxorubicin—muscle cancer	0.000347	0.00199	CcSEcCtD
Granisetron—Dyspnoea—Methotrexate—muscle cancer	0.000347	0.00199	CcSEcCtD
Granisetron—Somnolence—Methotrexate—muscle cancer	0.000346	0.00198	CcSEcCtD
Granisetron—Dry mouth—Doxorubicin—muscle cancer	0.000344	0.00197	CcSEcCtD
Granisetron—Dyspepsia—Methotrexate—muscle cancer	0.000342	0.00196	CcSEcCtD
Granisetron—Decreased appetite—Methotrexate—muscle cancer	0.000338	0.00194	CcSEcCtD
Granisetron—Oedema—Doxorubicin—muscle cancer	0.000337	0.00193	CcSEcCtD
Granisetron—Anaphylactic shock—Doxorubicin—muscle cancer	0.000337	0.00193	CcSEcCtD
Granisetron—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000336	0.00192	CcSEcCtD
Granisetron—Infection—Doxorubicin—muscle cancer	0.000335	0.00192	CcSEcCtD
Granisetron—Pain—Methotrexate—muscle cancer	0.000333	0.00191	CcSEcCtD
Granisetron—Shock—Doxorubicin—muscle cancer	0.000331	0.0019	CcSEcCtD
Granisetron—Nervous system disorder—Doxorubicin—muscle cancer	0.00033	0.00189	CcSEcCtD
Granisetron—Thrombocytopenia—Doxorubicin—muscle cancer	0.00033	0.00189	CcSEcCtD
Granisetron—Tachycardia—Doxorubicin—muscle cancer	0.000329	0.00188	CcSEcCtD
Granisetron—Skin disorder—Doxorubicin—muscle cancer	0.000327	0.00187	CcSEcCtD
Granisetron—Hyperhidrosis—Doxorubicin—muscle cancer	0.000326	0.00186	CcSEcCtD
Granisetron—Feeling abnormal—Methotrexate—muscle cancer	0.000321	0.00184	CcSEcCtD
Granisetron—Gastrointestinal pain—Methotrexate—muscle cancer	0.000318	0.00182	CcSEcCtD
Granisetron—Hypotension—Doxorubicin—muscle cancer	0.000315	0.0018	CcSEcCtD
Granisetron—Urticaria—Methotrexate—muscle cancer	0.000309	0.00177	CcSEcCtD
Granisetron—Body temperature increased—Methotrexate—muscle cancer	0.000308	0.00176	CcSEcCtD
Granisetron—Abdominal pain—Methotrexate—muscle cancer	0.000308	0.00176	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000307	0.00176	CcSEcCtD
Granisetron—Insomnia—Doxorubicin—muscle cancer	0.000305	0.00174	CcSEcCtD
Granisetron—Paraesthesia—Doxorubicin—muscle cancer	0.000302	0.00173	CcSEcCtD
Granisetron—Dyspnoea—Doxorubicin—muscle cancer	0.0003	0.00172	CcSEcCtD
Granisetron—Somnolence—Doxorubicin—muscle cancer	0.000299	0.00171	CcSEcCtD
Granisetron—Dyspepsia—Doxorubicin—muscle cancer	0.000297	0.0017	CcSEcCtD
Granisetron—Decreased appetite—Doxorubicin—muscle cancer	0.000293	0.00168	CcSEcCtD
Granisetron—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000291	0.00167	CcSEcCtD
Granisetron—Pain—Doxorubicin—muscle cancer	0.000288	0.00165	CcSEcCtD
Granisetron—Constipation—Doxorubicin—muscle cancer	0.000288	0.00165	CcSEcCtD
Granisetron—Hypersensitivity—Methotrexate—muscle cancer	0.000287	0.00164	CcSEcCtD
Granisetron—Asthenia—Methotrexate—muscle cancer	0.000279	0.0016	CcSEcCtD
Granisetron—Feeling abnormal—Doxorubicin—muscle cancer	0.000278	0.00159	CcSEcCtD
Granisetron—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000275	0.00158	CcSEcCtD
Granisetron—Pruritus—Methotrexate—muscle cancer	0.000275	0.00158	CcSEcCtD
Granisetron—Urticaria—Doxorubicin—muscle cancer	0.000268	0.00153	CcSEcCtD
Granisetron—Abdominal pain—Doxorubicin—muscle cancer	0.000266	0.00152	CcSEcCtD
Granisetron—Body temperature increased—Doxorubicin—muscle cancer	0.000266	0.00152	CcSEcCtD
Granisetron—Diarrhoea—Methotrexate—muscle cancer	0.000266	0.00152	CcSEcCtD
Granisetron—Dizziness—Methotrexate—muscle cancer	0.000257	0.00147	CcSEcCtD
Granisetron—Hypersensitivity—Doxorubicin—muscle cancer	0.000248	0.00142	CcSEcCtD
Granisetron—Vomiting—Methotrexate—muscle cancer	0.000247	0.00142	CcSEcCtD
Granisetron—Rash—Methotrexate—muscle cancer	0.000245	0.0014	CcSEcCtD
Granisetron—Dermatitis—Methotrexate—muscle cancer	0.000245	0.0014	CcSEcCtD
Granisetron—Headache—Methotrexate—muscle cancer	0.000244	0.0014	CcSEcCtD
Granisetron—Asthenia—Doxorubicin—muscle cancer	0.000242	0.00138	CcSEcCtD
Granisetron—Pruritus—Doxorubicin—muscle cancer	0.000238	0.00136	CcSEcCtD
Granisetron—Nausea—Methotrexate—muscle cancer	0.000231	0.00132	CcSEcCtD
Granisetron—Diarrhoea—Doxorubicin—muscle cancer	0.00023	0.00132	CcSEcCtD
Granisetron—Dizziness—Doxorubicin—muscle cancer	0.000223	0.00128	CcSEcCtD
Granisetron—Vomiting—Doxorubicin—muscle cancer	0.000214	0.00123	CcSEcCtD
Granisetron—Rash—Doxorubicin—muscle cancer	0.000212	0.00122	CcSEcCtD
Granisetron—Dermatitis—Doxorubicin—muscle cancer	0.000212	0.00122	CcSEcCtD
Granisetron—Headache—Doxorubicin—muscle cancer	0.000211	0.00121	CcSEcCtD
Granisetron—Nausea—Doxorubicin—muscle cancer	0.0002	0.00115	CcSEcCtD
